121 related articles for article (PubMed ID: 20380849)
1. Development of novel fibrinogen nanoparticles by two-step co-acervation method.
Rejinold NS; Muthunarayanan M; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
Int J Biol Macromol; 2010 Jul; 47(1):37-43. PubMed ID: 20380849
[TBL] [Abstract][Full Text] [Related]
2. Curcumin loaded fibrinogen nanoparticles for cancer drug delivery.
Rejinold NS; Muthunarayanan M; Chennazhi KP; Nair SV; Jayakumar R
J Biomed Nanotechnol; 2011 Aug; 7(4):521-34. PubMed ID: 21870456
[TBL] [Abstract][Full Text] [Related]
3. 5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications.
Rejinold NS; Muthunarayanan M; Chennazhi KP; Nair SV; Jayakumar R
Int J Biol Macromol; 2011 Jan; 48(1):98-105. PubMed ID: 20951162
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
5. In-vitro cytotoxicity and cell uptake study of gelatin-coated magnetic iron oxide nanoparticles.
Gaihre B; Hee Lee Y; Khil MS; Yi HK; Kim HY
J Microencapsul; 2011; 28(4):240-7. PubMed ID: 21545315
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured CaWO4, CaWO4 : Pb2+ and CaWO4 : Tb3+ particles: polyol-mediated synthesis and luminescent properties.
Wang Z; Lil G; Quan Z; Kong D; Liu X; Yu M; Lin J
J Nanosci Nanotechnol; 2007 Feb; 7(2):602-9. PubMed ID: 17450802
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake and degradation behaviour of biodegradable poly(ethylene glycol-graft-methyl methacrylate) nanoparticles crosslinked with dimethacryloyl hydroxylamine.
Scheler S; Kitzan M; Fahr A
Int J Pharm; 2011 Jan; 403(1-2):207-18. PubMed ID: 20969936
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
10. Hydrophobic grafted and cross-linked starch nanoparticles for drug delivery.
Simi CK; Emilia Abraham T
Bioprocess Biosyst Eng; 2007 May; 30(3):173-80. PubMed ID: 17278045
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.
Kumar S; Randhawa JK
Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent organic nanoparticles self-assembled from hexa[p-(carbonyl glycin methyl ester) phenoxy] cyclotriphosphazene in solution.
Li X; Li Z; Jing Y; Bing B; Li B
J Colloid Interface Sci; 2012 Jun; 375(1):41-9. PubMed ID: 22421000
[TBL] [Abstract][Full Text] [Related]
13. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
14. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of stearic acid-pullulan nanoparticles.
Kim IS; Oh IJ
Arch Pharm Res; 2010 May; 33(5):761-7. PubMed ID: 20512475
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
17. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.
Li Y; Wong HL; Shuhendler AJ; Rauth AM; Wu XY
J Control Release; 2008 May; 128(1):60-70. PubMed ID: 18406489
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of cyclodextrin complexed hydroxyapatite nanoparticles for preferential albumin adsorption.
Victor SP; Sharma CP
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):221-8. PubMed ID: 21458963
[TBL] [Abstract][Full Text] [Related]
20. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
